Distinguished in Colitis

Irit Biron-Avni

Petah Tiqwa, M, IL 
Distinguished in Colitis
Petah Tiqwa, M, IL 
OverviewLocationsClinical Research

Overview

Irit Biron-Avni practices in Petah Tiqwa, Israel. Ms. Biron-Avni is rated as a Distinguished expert by MediFind in the treatment of Colitis. Her top areas of expertise are Viral Gastroenteritis, Crohn's Disease, Colitis, Ileostomy, and Endoscopy.

Her clinical research consists of co-authoring 42 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 16 articles in the study of Colitis.

Gender
Female

Locations

Petah Tiqwa, M, Israel
Other Locations
Tel Aviv, TA, Israel

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study
A Follow-up of a Phase 3 Study to Evaluate the Long-term Safety and Efficacy of Darvadstrocel in the Treatment of Complex Perianal Fistula in Subjects With Crohn's Disease Who Have Participated in ADMIRE II Study
Enrollment Status: Completed
Publish Date: April 23, 2025
Intervention Type: Biological, Other
Study Drug: Darvadstrocel Adipose Stem Cell Transplantation
Study Phase: Phase 3
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
A Randomized, Double Blind, Placebo-controlled, Multicenter, Parallel Group Study to Assess the Efficacy and Safety of Fixed-dose Combination RHB-104 in Subjects With Moderately to Severely Active Crohn's Disease
Enrollment Status: Completed
Publish Date: December 08, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

42 Total Publications

Drug persistence of first- and advanced-line therapy for chronic inflammatory pouch disorders: A prospective cohort spanning sequential treatment lines.
Drug persistence of first- and advanced-line therapy for chronic inflammatory pouch disorders: A prospective cohort spanning sequential treatment lines.
Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Published: September 06, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Biron-Avni's expertise for a condition
ConditionClose
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile